Vanguard Group Inc Dare Bioscience, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,358,215 shares of DARE stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,358,215
Previous 3,450,328
2.67%
Holding current value
$14 Million
Previous $1.69 Million
32.49%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DARE
# of Institutions
20Shares Held
7.13MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA1.01MShares$4.19 Million0.0% of portfolio
-
Amh Equity LTD924KShares$3.84 Million0.44% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny779KShares$3.24 Million0.0% of portfolio
-
State Street Corp Boston, MA282KShares$1.17 Million0.0% of portfolio
-
Black Rock Inc. New York, NY204KShares$847,1090.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $353M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...